University of South Florida researchers recently discovered people with rheumatoid arthritis are less likely to develop Alzheimer's disease than people without the chronic disease, known for causing inflammation of the joints.
Researchers also have reason to believe that the recombinant human form of GM-CSF (Leukine), commonly used in the treatment of cancer patients, could be used as a potential treatment for Alzheimer's disease.
The
USF Health Byrd Alzheimer's Institute expects a pilot clinical trial will begin this year.
The study, titled "GM-CSF up-regulated in Rheumatoid Arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice," is available at the
Journal of Alzheimer's Disease.
Read the complete
article.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.